Registration Options

Activity Dates: 05/16/2019 - 04/10/2022

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

Within the past several decades, the United States and other countries around the world have seen an increased prevalence of long-term antidepressant use. While evidence for the long-term use of antidepressants exists, particularly in relation to relapse prevention, there is still a lack of robust data regarding overall long-term use, the optimal length of antidepressant treatment, and particular patient factors that may influence the benefits or risks of continued, long-term use of antidepressant medications. Psychiatric pharmacists are well-suited to help treatment teams identify the benefits and risks for long-term use of antidepressant medications and make patient-centered decisions about continued antidepressant use.

This program will provide participants with information regarding the current trends in the long-term use of antidepressants, the benefits and risks of continued long-term use, and the factors related to making the most patient-centered decisions about continued, long-term use of antidepressant medications.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Complete the pre-test before starting the activity.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Participants in this course must complete an examination and achieve a score of 70% or greater. Successful completion of the course also requires the completion of a course evaluation. Upon successful completion, ACPE credit is reported immediately to CPE Monitor although transcripts can be retrieved by participants online at https://aapp.org/mycpnp/transcript/acpe.

Faculty Information and Disclosures

Learning Objectives

  1. Identify guideline recommendations for continuance and maintenance of antidepressant drug therapy after a first depressive episode.
  2. Outline the potential benefits of long-term antidepressant medication management.
  3. Define the potential hazards in long-term antidepressant use.
  4. Identify key patient-specific factors that may warrant continuation of long-term antidepressant use vs. de-prescribing of antidepressants.

Continuing Education Credit and Disclosures

Activity Dates: 05/16/2019 - 04/10/2022
ACPE Contact Hours: 1
ACPE Number: 0284-0000-19-033-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This course provides 1.0 contact hour of knowledge-based continuing education credit from CPNP approved programming.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.

Grant Support

Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Lundbeck